RIGHT TO TRY INDIVIDUALIZED TREATMENTS ACT

SB 33, the "Right to Try Individualized Treatments Act," allows New Mexico residents with life-threatening or severely debilitating illnesses (after exhausting all FDA-approved treatments) to access individualized investigational treatments based on their genetic profile. The law requires written informed consent from patients detailing treatment options and risks, and permits manufacturers to provide these treatments without charge or require patient payment. It does not mandate insurance coverage for these treatments, but protects patients' heirs from liability for treatment debts after death and shields healthcare providers from disciplinary action for recommending such treatments. The bill also prohibits state officials from blocking patient access to these treatments.